Metabolic polymorphisms have long been recognized as important determi
nants of carcinogen susceptibility and recent efforts have shown that
interindividual differences in specific cytochromes P450, acetyltransf
erases, sulfotransferases and glutathione S-transferases are often dis
proportionately represented in epidemiological studies between cancer
cases and controls. Concomitantly, biomonitoring of carcinogen-DNA add
ucts in human tissues using immunochemical, (32)p-postlabelling, fluor
escence, and mass spectrometric methods have recently provided direct
evidence of human exposure to genotoxic aromatic and heterocyclic amin
es, polycyclic hydrocarbons, alkylating agents, and endogenous product
s. However, a combined approach is now needed in order to assess the r
elevance of these findings to cancer etiology, to identify high-risk i
ndividuals, and to provide better health monitoring, earlier diagnosis
, and cancer prevention. Using this paradigm, results are presented th
at implicate specific aromatic amines, heterocyclic amines, and polycy
clic aromatic hydrocarbons in the etiology of human urinary bladder, c
olon, and laryngeal cancers.